Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57K Buy
+400
New +$1.16K ﹤0.01% 4872
2025
Q2
Sell
-122,516
Closed -$186K 5216
2025
Q1
$186K Sell
122,516
-64,387
-34% -$120K ﹤0.01% 4084
2024
Q4
$372K Hold
186,903
﹤0.01% 4001
2024
Q3
$415K Hold
186,903
﹤0.01% 3890
2024
Q2
$572K Buy
186,903
+11,773
+7% +$31.6K ﹤0.01% 2967
2024
Q1
$490K Buy
+175,130
New +$545K ﹤0.01% 3606

Other funds holding ADAG

Barclays's ADAG Position: Q1 2026 in Review

Barclays opened a new position in Adagene (ADAG) in Q1 2026: 400 shares worth $1.57K. The stake represents ﹤0.01% of the portfolio and ranks #4872 among its holdings. This is a return to the name: Barclays previously reported a position in ADAG as recently as Q1 2025.

Barclays first reported a position in ADAG in Q1 2024 and has held it in 6 quarters since. The position peaked at $572K in Q2 2024. 25 funds tracked by Wall St. Rank hold ADAG as of Q1 2026.

  • Barclays held 400 shares of Adagene worth $1.57K as of Q1 2026.
  • Adagene was a new Barclays position in Q1 2026.
  • Adagene made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4872 holding.
  • Barclays first reported a position in Adagene in Q1 2024 and has held it in 6 quarters since.
  • Barclays's Adagene position peaked at $572K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Adagene as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.